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Tonsillectomy is associated with severe postoperative pain for which, several drugs are employed 
for management.
Objective: In this double-blind, placebo-controlled study we aimed to evaluate the efficacy of 
intravenous paracetamol and dipyrone when used for post-tonsillectomy analgesia in children.
Method: 120 children aged 3-6 yr, undergoing tonsillectomy with or without adenoidectomy and/
or ventilation tube insertion were randomized to receive intraoperative infusions of paracetamol (15 
mg/kg), dipyrone (15 mg/kg) or placebo (0.9% NaCl). Evaluation was carried out at 0.25, 0.50, 1, 2, 
4, 6h postoperatively. Pethidine 0.25 mg/kg was utilized as rescue analgesic. Cumulative pethidine 
requirement was the primary outcome. Pain intensity measurement, pain relief, sedation level, nausea 
and vomiting, postoperative bleeding and any other adverse effects were noted.
Results: No significant difference was found in pethidine requirement between paracetamol and 
dipyrone groups. Cumulative pethidine requirement was significantly less in paracetamol and dipy-
rone groups vs. placebo. No significant difference was observed between groups in postoperative 
pain intensity scores throughout the study.
Conclusion: Intravenous paracetamol is found to have a similar analgesic efficacy as intravenous 
dipyrone and they both help to reduce the opioid requirement for postoperative analgesia in pedi-
atric day-case tonsillectomy.
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INTRODUCTION
Tonsillectomy with or without adenoidectomy is 
associated with severe postoperative pain and presently 
forms a major part of day-case pediatric anesthetic mana-
gement1. It is important to provide effective and safe pain 
control in this patient group allowing early ambulation. 
Potential for respiratory depression, nausea and vomiting 
limits the use of opioid analgesics particularly in this patient 
group when care of the patient is parents’ responsibility 
after early discharge2,3 particularly following a surgical 
procedure involving the upper respiratory pathway4. Di-
pyrone has a substantial use in many centers5-8 however 
it is reluctantly used and even taken off the market in 
some countries9 due to data that it may increase the risk 
of agranulocytosi10. Intravenous paracetamol with a well 
established safety profile may be a reasonable alternative in 
these patients11. Paracetamol in oral and rectal suppository 
forms have long been used for postoperative analgesia in 
children12; however irregular bioavailability of rectal form 
and temporary prohibition of oral intake in post tonsil-
lectomy patients are important factors limiting the use of 
paracetamol in immediate postoperative management of 
pain following tonsillectomy13.
Recently, following introduction of intravenous form 
of paracetamol with more predictable pharmacodynamic 
properties when compared with its other forms11, safety 
and efficacy of intravenous paracetamol has been tested 
in various postoperative clinical scenarios14 but there are 
still only a few publications about efficacy of intravenous 
paracetamol administration for postoperative pain mana-
gement in pediatric age group2,14-18.
Particularly there is lack of data involving intrave-
nous paracetamol and intravenous dipyrone in a placebo 
controlled setting which may be used as evidence that 
intravenous paracetamol might be a reasonable alternati-
ve for dipyrone for post-tonsillectomy pain management 
among pediatric age group. The aim of this study is to 
evaluate the efficacy of intravenous paracetamol and 
intravenous dipyrone in a placebo controlled setting for 
postoperative pain management during day case tonsil-
lectomy in pediatric age group.
METHOD
The protocol was approved by the Ethics Committee 
of University Faculty of Medicine (project no: KA08/46). 
Following written informed parental consent and verbal 
child assent had been obtained, consecutive patients age 
between 3-6 year who were scheduled for elective day case 
tonsillectomy together with or without adenoidectomy and/
or ventilation tube insertion in our university hospital were 
screened for eligibility for enrollment in this prospective, 
randomized, double blind, placebo controlled study.
Extreme care is undertaken in order to manage 
pain in all groups including the placebo group by strict 
adherence for rescue opioid analgesic medication in each 
and every assessment interval. Inclusion criteria were 
patient physical status ASA I; scheduled day-case elective 
operation. Exclusion criteria were emergency surgery; 
known hypersensitivity to the drugs under study; history of 
renal, hepatic, respiratory or cardiac disease; neurological 
or neuromuscular disorders; known glucose 6 phosphate 
dehydrogenase deficiency concomitant medication (anti-
convulsants, corticosteroids, period before the study.
Following screening, eligible patients were ran-
domized to receive a single dose of either intravenous 
paracetamol 15 mg/kg premixed with 0.9% NaCl to a total 
of 50 ml, intravenous dipyrone 15 mg/kg premixed with 
0.9% NaCl to a total of 50 ml or 50 ml of 0.9% NaCl as pla-
cebo according to a pre-generated randomization scheme 
created by the web site Randomization.com (http://www.
randomization.com). Patients, all care givers and the cli-
nical observers who scored were blinded to the allocated 
treatment of the individual patient. All study medications 
were prepared by a clinician unaware of the patient’s allo-
cated study group in identical infusion pumps. Infusions 
were administered by a blinded attending physician. All 
study medications were infused as a single dose following 
induction of general anesthesia. All patients were preme-
dicated with 0.3 mg/kg oral midazolam and 0.2 mg/kg 
intravenous dexamethasone before surgery.
General anesthesia was induced by thiopental 
3-5 mg/kg, fentanyl 1 mg/kg and vecuronium 0.1 mg/
kg. After tracheal intubation, mechanical ventilation was 
initiated, and a 50% mixture of N
2
/O
2
 was administered 
throughout the surgery. Anesthesia was maintained with 
isoflurane 1.0-1.2 MAC. No additional opioid was given 
intraoperatively. At the end of the operation residual 
neuromuscular block was reversed with neostigmine 
0.04 mg/kg and atropine 0.02 mg/kg. Endotracheal tube 
was removed when respiration was regular and adequate 
according to the discretion of the attending physician. 
Patients were transferred to post anesthesia care unit after 
the removal of endotracheal tube. Investigators recorded 
the study variables 0.25, 0.5, 1, 2, 4, and 6h after arrival 
to post anesthesia care unit. Pain intensity was assessed 
by Children’s Hospital East Ontario Pain Scale (CHEOPS) 
with range of scores 4-1319.
Pain relief (PR) was assessed by a 5 point verbal scale 
(16) rated by the investigator indicating 0 = none, 1 = a 
little, 2 = moderate, 3 = a lot, 4 = complete. Sedation level 
was assessed by a 4 point scale rated by the investigator 
indicating 0 = eyes open spontaneously, 1 = eyes open to 
speech, 2 = eyes open to gentle shaking, 3 = unarousable. 
Nausea and vomiting were assessed by a 3 point scale rated 
by the investigator indicating 0 = no nausea, 1 = nausea 
without vomiting in the evaluation period, 2 = vomiting in 
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the evaluation period. In case of CHEOPS score > 6 and/
or PR score < 2, the patient received 0.25 mg/kg pethidine 
in to a maximum total dose of 1.5 mg/kg in 6 hours as 
rescue analgesic medication until CHEOPS score was ≤ 6 
and PR ≥ 2. Metoclopramide 0.1 mg/kg was used as an 
antiemetic for recurrent nausea or vomiting. Duration of 
post anesthesia care unit stay was recorded. Any hemor-
rhage requiring intervention at the surgical site and other 
adverse effects attributable to any drug effect were also 
noted. Patients meeting standard discharge characteristics 
(awake, hemodynamically stable, maintaining a patent 
airway without support, protective reflexes intact, free of 
adenotonsillary persistent bleeding, and comfortable) were 
discharged from post anesthesia care unit.
A priori power analysis was performed on the basis 
of the cumulative pethidine requirement data obtained 
from the first 15 patients in the placebo group among the 
present study. The results of the first 15 patients in the 
placebo group showed that mean cumulative pethidine 
requirement was 0.62 ± 0.29 mg/kg during the first 6 
hours postoperatively. In order to detect a 30% reduction 
in the dose of cumulative pethidine requirement between 
an active treatment group and placebo with 80% power 
at a = 0.05; power analysis suggested a sample size of 38 
per each group. Analysis was performed by Power and 
PrecisionTM (Biostat Inc., Englewood, NJ) statistical pro-
gram. Differences among the three groups were analyzed 
by an analysis of variance test or its nonparametric counter-
part, the Kruskal-Wallis test. The homogeneity of variances 
was calculated with the Levene test and the Lilliefors signi-
ficance correction test. Post hoc analyses were performed 
with the Bonferroni test. Either the chi-square or Fisher’s 
exact test was used to analyze categorical variables when 
appropriate. Differences were considered statistically 
significant at p < 0.05. Data were expressed on means ± 
SD or median (25-75). Statistical calculations were perfor-
med with SPSS software (Statistical Package for the Social 
Sciences, version 11.0; SSPS Inc, Chicago, IL).
RESULTS
One hundred thirty eight patients were screened to 
participate in this study. During screening nine patients 
were found to be not eligible for the study, seven patients’ 
parents declined to give consent and two patients were 
excluded due to other reasons. A total of 120 patients 
constituted the study population. Each group comprised 
of 40 cases. There were no differences among groups 
with regard to age distribution, weight, sex, type of the 
operation, and duration of the operation (Table 1). There 
was no difference in the CHEOPS score between groups 
at any time interval during follow up (Figure 1).
There was no difference between groups among 
pain relief score at 0.25, 1, and 2h during follow up; 
however pain relief score in paracetamol group was signi-
ficantly higher than placebo group at 0.5 and 4h follow up 
(p = 0.04; p = 0.01 respectively). There were no differences 
between dipyrone vs. placebo and dipyrone vs. paracetamol 
groups with regard to pain relief score at 0.5h follow up. 
At 6h follow up, pain relief score was significantly higher 
in paracetamol group when compared with placebo (p < 
0.001) and dipyrone (p = 0.04) groups. Also at 6h follow 
up pain relief score was significantly higher in dipyrone 
group than placebo group (p = 0.03) (Figure 2).
Cumulative pethidine use as a rescue analgesic 
was not different among groups at 0.25, 0.5, 1, 2, and 4h 
follow up; however at 6h follow up both paracetamol vs. 
placebo and dipyrone vs. placebo comparisons revealed 
significantly lower rescue analgesic requirement in active 
treatment groups (0.45 ± 0.30 mg/kg [95% CI 0.35-0.55] 
vs 0.67 ± 0.38 mg/kg [95% CI 0.55-0.79], p = 0.01; 0.48 
± 0.30 mg/kg [95% CI 0.38-0.57], vs. 0.67 ± 0.38 mg/kg 
[95% CI 0.55-0.79], p = 0.03 respectively). Cumulative 
pethidine requirement was similar between paracetamol 
Table 1. Demographic data and operative characteristics.
Paracetamol 
(n = 40)
Dipyrone 
(n = 40)
Placebo 
(n = 40) p
Age (yr) 4.7 ± 1.0 4.6 ± 0.9 4.3 ± 1.0 0.222
Sex (male/female) 29/11 27/13 19/21 0.05
Weight (kg) 16.9 ± 3.3 18.0 ± 5.2 17.7 ± 4.5 0.53
Type of the 
operation 0.901
Tonsillectomy 34 35 33
Adenotonsillectomy 4 4 4
Adenotonsillectomy 
+ ETI 2 1 3
Duration of surgery 
(min) 36.9 ± 12.1 42.1 ± 12.7 36.6 ± 14.6 0.123
Data expressed as mean ± standard deviation. ETI: ear tube insertion.
Figure 1. CHEOPS score among groups. Data expressed as Median 
(25-75 centile). No significant difference at any time interval between 
any group.
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and dipyrone groups. (Figure 3). Number of patients who 
had nausea, vomiting or antiemetic administration during 
the study were similar among all three groups (Figure 4). 
There was no difference among sedation score between 
groups at any time interval during follow up (Figure 5).
Figure 2. Pain relief score among groups. Data expressed as Median 
(25-75 centile). * Pain relief score significantly higher in iv.paracetamol 
group vs. placebo in 0.5,4 and 6 h. (p: 0.04; p: 0.01; p less than 0.001 
respectively). # Pain relief score significantly higher in iv. paracetamol 
group vs. iv. dipyrone in 6h. (p: 0.04). ¥ Pain relief score significantly 
higher in iv dipyrone vs. placebo in 6h. (p: 0.03).
Figure 3. Cumulative pethidine requirement. Data expressed as 
mean ± SD. * Dipyrone significantly decrease pethidine requirement 
compared to placebo (p: 0.03). # Paracetamol significantly decrease 
pethidine requirement compared to placebo (p: 0.01).
Figure 4. Data among nausea and vomiting.
Figure 5. Sedation score among groups. Data expressed as Median 
(25-75 centile) No significant difference at any time interval between 
any group.
Duration of stay in the post anesthesia care unit was 
similar between groups (paracetamol 36.12 ± 14.52 min (95% 
CI 31.48-40.76); dipyrone 41.02 ± 14.28 min (95% CI 36.39-
45.65); placebo 41.12 ± 14.99 min (95% CI 36.32-45.92); p 
= 0.22) There were no significant adverse events during the 
study. One patient underwent re-operation after 6h follow 
up postoperative bleeding due to surgery in the dipyrone 
group, however this single bleeding case did not have any 
statistical significance between groups. All randomized 
patients were taken into statistical analysis.
DISCUSSION
In this prospective, randomized, double blind, pla-
cebo controlled study both intravenous paracetamol and 
dipyrone yielded similar efficacy with lower cumulative 
doses of opioid requirement in the first 6 hours during 
post-tonsillectomy analgesia in pediatric age group when 
compared with placebo.
Despite it is widely perceived that tonsillectomy 
needs prompt postoperative analgesic management as it 
is associated with severe pain, there is lack of a universal 
approach for these patients which is accepted as ideal20,21. 
There is no single agent proved to be effective solely, and 
the management of this clinical dilemma in the contempo-
rary practice mostly comprises of a multimodal approach 
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including regular non-opioid analgesics followed by indi-
vidually titrated opioid drugs when necessary21. There are 
only a few options for intravenous non-opioid analgesia in 
postoperative pain management at pediatric age group22. 
Paracetamol1,2,15-18 and dipyrone1,5,6 are two commonly 
used intravenous analgesics for this indication. Intrave-
nous paracetamol vs. intravenous dipyrone is compared 
in postoperative pain management in a variety of settings 
including retinal, maxillofacial, urological, gynecological, 
and orthopedic, and breast surgery in adult population23-26. 
Results of these studies revealed similar clinical efficacy 
between these two agents except one study25 implying a 
potential advantage of paracetamol over dipyrone. In the 
pediatric age group there is general lack of information on 
use of medications compared with adults27 and there is a 
strong initiative across Europe to overcome this paucity of 
data28. Our study revealed similar analgesic effect of intra-
venous paracetamol vs. dipyrone reflected by equivalent 
CHEOPS scores and cumulative pethidine requirement 
among two active treatment groups.
Nevertheless, paracetamol may be offering some 
advantage over dipyrone in terms of pain relief score 
postoperatively. One of the main findings of our study 
is the lack of difference with regard to CHEOPS scores 
between active treatment groups and placebo. Previous 
studies evaluating post tonsillectomy analgesia in pediatric 
age group evaluating intravenous paracetamol vs. opioid 
drugs2,15,18 revealed either equivalent or a slightly lower 
analgesic effect of this drug than pethidine or tramadol; 
however these studies were not placebo controlled there-
fore any comment on the analgesic efficacy of intravenous 
paracetamol compared with placebo cannot be ascertained 
from them. Our placebo controlled study differs from 
them particularly by giving an opportunity to comment 
on effects of these two active treatment regimens when 
compared with placebo. Although paracetamol at 0.5, 4, 
6h and dipyrone at 6h follow up offered some benefit in 
terms of higher pain relief scores when compared with 
placebo, it can only be regarded as a minimal clinical be-
nefit over placebo as the pain intensity score was similar 
between all three groups.
Contrary to the data published by Landwehr et al.23, 
showing a clear benefit by both paracetamol and dipyrone 
over placebo during adult retinal surgery; another recent 
placebo controlled study published by Ohnesorge et al.25, 
did not show a significantly different effect on pain inten-
sity of neither intravenous paracetamol nor intravenous 
dipyrone over placebo in adult patients undergoing breast 
surgery. Our study revealed a lower cumulative dose of 
opioid requirement at 6h follow up. Although the cumu-
lative opioid requirement was similar between groups in 
the study of Ohnesorge et al.25, the number of patients 
requiring opioid analgesia in the first postoperative day 
was lower in the paracetamol group which can be regar-
ded as a slight opioid sparing effect. On the other hand, 
while there was no opioid sparing effect of dipyrone in 
that study, our study also revealed an opioid sparing effect 
of intravenous dipyrone at 6h follow up over placebo.
The main differences between two studies were 
the adult vs. pediatric age group of the patients recruited 
and the nature of surgical procedures. Cumulative dose 
of pethidine requirement were similar in active treatment 
and placebo groups until 4th hour postoperatively; and the 
difference between active treatment groups and placebo 
group was detectable only on the 6th postoperative hour. 
That finding probably reflects the analgesic effect of fen-
tanyl used intraoperatively during anesthesia induction 
which may last approximately 4 hours in this age group29. 
Postoperative nausea and vomiting (PONV) was previously 
correlated with opioid drugs30 and pain31. In our study, 
PONV was equivalent among all three groups. Although it 
was previously shown that increasing opioid dose is asso-
ciated with increasing PONV incidence32,33 premedication 
with steroids might have prevented PONV in the placebo 
group who received a higher cumulative opioid dose. 
Another factor for this equivalence may be the equivalent 
pain intensity among all three groups. Duration of stay in 
post anesthesia care unit was similar in all three groups 
probably reflecting the equivalent level of sedation and 
pain intensity among them.
Limitation of our study is the measurement of pain 
only at rest but not during swallowing, this would yield 
more information about the clinical efficacy of these agents.
CONCLUSION
In conclusion, intravenous paracetamol and di-
pyrone used for analgesia in the early postoperative pe-
riod after day case tonsillectomy in pediatric age group 
yielded efficient analgesia with lower cumulative doses 
of pethidine requirement when compared with placebo. 
Clinical benefit created by both paracetamol and dipyrone 
was confined to increased pain relief in 6h follow up and 
lower cumulative dose of pethidine requirement. Lower 
pethidine requirement did not lead to an effect on the 
incidence of opioid-related side effect incidence among 
groups (PONV, sedation). Contemporary methods used 
for relieving post tonsillectomy pain in the pediatric age 
group is still far from ideal and research is still demanded 
to fulfill this requirement.
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